Skip to main content

Drummond Interviewed by WRAL on the Effects of Vaping

June 30, 2022
M. Bradley Drummond, MD MHS, was interviewed on WRAL News on the effects of vaping and smoking in light of the FDA’s decision to remove Juul e-cigarettes off the market. The video of the interview can be seen here.

Hagood Awarded Grant from Harrington Discovery Institute

May 6, 2022
James S. Hagood, MD, professor in the UNC Department of Pediatrics and Director of the Program for Rare and Interstitial Lung Disease of the UNC Children’s Research Institute and Marsico Lung Institute, has been selected as a Harrington Scholar-Innovator for his work on a therapeutic Strategy for pulmonary fibrosis. Read...

Vogt Interviewed for WTVD News Brief on COVID-19 in Young Children

May 6, 2022
Matthew R. Vogt, MD, PhD, was interviewed for an ABC11 WTVD news brief on the increase of COVID-19 cases in young children. The news brief can be viewed here.

Ehre’s Research on Asthma and COVID-19 Featured in Multiple News Stories

May 6, 2022
Research conducted by the lab of Camille Ehre, PhD, has been featured in multiple news stories across a range of websites. The research, focusing on asthma, COVID-19, and the cytokine IL-13, was initially published in PNAS by Morrison, Ehre, et al under the title “SARS-CoV-2 infection of airway cells causes intense...

Vogt & Hernandez Enroll Children in PREMISE Study to Prevent Next Pandemic, Focused on Virus Infection that Paralyzes like Polio

April 21, 2022
Matthew Vogt, MD, PhD, and Michelle Hernandez, MD, initiate pandemic preparedness study focused on children with NIAID Vaccine Research Center. Read the full story here.

Peden Consulted for Medscape Article on Early Allergen Immunotherapy to Prevent Future Asthma

April 19, 2022
David Peden, MD, MS, was consulted for a Medscape article on the use of early allergen immunotherapy for the prevention of future asthma. The article, “Can Early Allergen Immunotherapy Prevent Future Asthma?,” can be read here.

Vogt Wins $3.1M NIAID Grant to Develop New Monoclonal Antibodies

March 31, 2022
Matthew Vogt, MD, PhD, was awarded an R01 from NIAID to generate new monoclonal antibodies in hopes of informing pan-enterovirus vaccines. Read the full story here.

Ehre Investigates Why People with Allergic Asthma Are Less Susceptible to Severe COVID

March 31, 2022
UNC-Chapel Hill scientists led by Camille Ehre, PhD, show how cells packed with SARS-CoV-2 detach from the upper airway and spread deep into lungs where severe COVID can take root. They also discovered how an asthmatic reaction to allergens battles the virus to hold severe COVID at bay. Read the...

Hernandez Study: Patient-Centered Intervention Improved Asthma Outcomes for Black and Latinx Adults

March 10, 2022
Black and Latinx patients who used an inhaled glucocorticoid as needed along with usual care had improved asthma outcomes, according to results from a PREPARE, PeRson EmPowered Asthma RElief, trial. Michelle Hernandez, MD, Professor of Pediatrics, was the UNC School of Medicine principal investigator and worked with the study lead,...

Kreda, Leigh, & Ostrowski Selected for SOM Translational Team Science Award

March 3, 2022
The Translational Team Science Awards (TTSA) program is aimed at capitalizing on UNC-Chapel Hill’s culture of collaboration and fostering interdisciplinary teams of basic science and clinical investigators. We are pleased to announce that one of the three teams receiving the TTSA Phase 1 Award for 2021-22 consists of the Marsico...